» Articles » PMID: 9453489

Genetic Analysis of Long-term Barrett's Esophagus Epithelial Cultures Exhibiting Cytogenetic and Ploidy Abnormalities

Overview
Specialty Gastroenterology
Date 1998 Feb 7
PMID 9453489
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: Progression to cancer in Barrett's esophagus occurs through an accumulation of cell cycle and genetic abnormalities that have been documented in vivo. To better study neoplastic evolution in Barrett's esophagus, the aim of this study was to establish in vitro cultures from preneoplastic tissues.

Methods: Mechanical and enzymatic dissociation methods were used to initiate Barrett's epithelial cultures from endoscopic biopsy specimens, and the cells were characterized using flow-cytometric, cytogenetic, and molecular genetic analyses.

Results: Four long-term cultures were established from 39 attempts. All cultures contain cytogenetic abnormalities and elevated flow-cytometric 4N DNA content fractions. Molecular genetic abnormalities detected include the following: 9p and/or CDKN2/p16 abnormalities in 4 of 4 cultures, 17p loss of heterozygosity and p53 mutation in 3 of 4 cultures, and 5q loss of heterozygosity in 1 of 4 cultures. Inactivation of p53 was statistically associated with successful long-term culture.

Conclusions: These cultures contain cell cycle and molecular genetic abnormalities that closely parallel those previously documented to occur early in cancer development in Barrett's esophagus in vivo. These alterations also appear to be associated with successful growth in vitro. The cultures may provide a premalignant in vitro system in which to test potential therapies for Barrett's esophagus as well as to examine etiologic factors and genetic intermediates important in neoplastic progression.

Citing Articles

Review of hTERT-Immortalized Cells: How to Assess Immortality and Confirm Identity.

Shitova M, Alpeeva E, Vorotelyak E Int J Mol Sci. 2024; 25(23).

PMID: 39684765 PMC: 11641324. DOI: 10.3390/ijms252313054.


Cell Immortality: Effective Techniques to Achieve and Investigate Its Applications and Challenges.

Chalak M, Hesaraki M, Mirbahari S, Yeganeh M, Abdi S, Rajabi S Life (Basel). 2024; 14(3).

PMID: 38541741 PMC: 10971253. DOI: 10.3390/life14030417.


Therapeutic Synergy in Esophageal Cancer and Mesothelioma Is Predicted by Dynamic BH3 Profiling.

Surman D, Xu Y, Lee M, Trepel J, Brown K, Ramineni M Mol Cancer Ther. 2021; 20(8):1469-1480.

PMID: 34088830 PMC: 8338890. DOI: 10.1158/1535-7163.MCT-20-0887.


Loss of SMAD4 Is Sufficient to Promote Tumorigenesis in a Model of Dysplastic Barrett's Esophagus.

Gotovac J, Kader T, Milne J, Fujihara K, Lara-Gonzalez L, Gorringe K Cell Mol Gastroenterol Hepatol. 2021; 12(2):689-713.

PMID: 33774196 PMC: 8267443. DOI: 10.1016/j.jcmgh.2021.03.008.


Evidence that polyploidy in esophageal adenocarcinoma originates from mitotic slippage caused by defective chromosome attachments.

Scott S, Li X, Jammula S, Devonshire G, Lindon C, Fitzgerald R Cell Death Differ. 2021; 28(7):2179-2193.

PMID: 33649470 PMC: 8257792. DOI: 10.1038/s41418-021-00745-8.